Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Antares Pharma has entered into a licensing contract with Pfizer’s Consumer Healthcare Business Unit for the development of an undisclosed product on an exclusive basis for North America.
Subscribe to our email newsletter
Pfizer is responsible for the clinical development, manufacturing, and commercialization of the product in the licensed territory, as well as certain non-exclusive territories outside of North America.
As per the contract, Antares will receive undisclosed upfront payments, development milestones and sales based milestones, and royalties on net sales for three years post launch in the US.
Antares president and CEO Paul Wotton said the collaboration with Pfizer Consumer Healthcare is an important product opportunity targeting a growing therapeutic area which utilizes one of their technology platforms.